• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • KTO
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • SGSC Global Bootcamp 2021
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • SGSC Demo Day
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • register
  • login
KoreaTechDesk
No Result
View All Result
KoreaTechDesk
No Result
View All Result
Home AI & Big Data

Korean startup VUNO Med’s cardiac arrest prediction medical device DeepCARS gets government approval

KoreaTechDesk Writer by KoreaTechDesk Writer
August 24, 2021
in AI & Big Data, Health & Bio
0
VUNO Med's DeepCARS predicts cardiac arrest.

VUNO Med's DeepCARS predicts cardiac arrest.

0
SHARES
840
VIEWS
Share on FacebookShare on Twitter

Korean MedTech startup VUNO solidifies its position in the AI in Medical sector as it gets approval from the Ministry of Food and Drug Safety for its AI-based cardiac arrest prediction medical device – VUNO Med®–DeepCARS. VUNO Med DeepCARS™ provides a risk of cardiac arrest based on four vital signs: blood pressure (diastolic, systolic), pulse, respiration, and body temperature collected from electronic medical records (EMR) of hospitalized patients in general wards.  

VUNO Med®–DeepCARS™ predicts Cardiac Arrest 

VUNO Med®–DeepCARS™,has proven its excellent predictive performance of cardiac arrest through mentions in a number of academic journals such as the Journal of the American Heart Association (JAHA) and the World Journal of Critical Care (CCM), including ‘Resuscitation’, as well as clinical trials conducted at Asan Medical Center in Seoul.

VUNO Med’s DeepCARS™ had been designated as an Innovative Medical Device by the Ministry of Food and Drug Safety (MFDS) in 2020. Hyun-Jun Kim, CEO of VUNO, said, “VUNO Med®–DeepCARS™ makes predictions about cardiac arrest based on a variety of vital signs to allow for early detection and swift response. Obviously, this epoch-making solution will serve as a game-changer once it comes into clinical use.” He added, “VUNO is dedicated to pioneer groundbreaking AI-based solutions across various medical fields from deep learning-based solutions using medical images to technologies regarding vital signs.”

VUNO’s solution helps medical staff recognize the risk of cardiac arrest in patients in advance and take appropriate measures. In general wards, it is difficult to continuously monitor patients compared to intensive care units, so realistic limitations have been pointed out in responding to severely exacerbated patients. In particular, in-hospital cardiac arrest, which has a high mortality rate of 75%, occurs at 5.17 cases per 1,000 hospitalizations based on tertiary general hospitals, which calls for improvement of the domestic inpatient monitoring system.

VUNO Med®–DeepCARS™ has the advantage that it can be used in various clinical environments in the future due to its high versatility using only essential vital signs that are generally measured in hospitalized patients. Yeha Lee, Chairman of VUNO’s Board of Directors, said, “VUNO Med®–DeepCARS™ is a groundbreaking AI medical device for predicting cardiac arrest that has proven clinical effectiveness in clinical studies conducted with various medical institutions. I will contribute to saving the lives of many patients,” he said. In addition, he added, “With this approval of VUNO Med®–DeepCARS™, we will expand the application of biosignal-based AI technology with high growth potential at home and abroad.”

According to a research paper published in Critical Care Medicine (CCM) in February 2020, VUNO Med®–DeepCARS™ had a level of sensitivity twice as high as Modified Early Warning Score (MEWS) – a conventional way of cardiac arrest prediction – for the same number of alarms. Added to this, VUNO Med®–DeepCARS™ showed a decrease of 59.6% in the total number of alarms for the same level of sensitivity, thus proving a low false alarm rate. Thus, expectations are growing that the implementation of VUNO Med®–DeepCARS™ at the forefront of medical care will lessen medical professionals’ fatigue from false alarms and help prevent cardiac arrest among inpatients by making considerably accurate predictions.

Also Read, 

  • Korean startup Nemesis Co, Ltd. developing SoC for biomedical devices
  • Korean company Carima contributes to fighting COVID-19 with 3D Printing of NP swabs & face shields
  • Korean Medical AI startup Lunit secures $26 million funding for global expansion
  • AIRS Medical: Set to revolutionise the Global Medical AI field
What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: Artificial IntelligenceCardiac Arrest PredictionDeepCARSKorean StartupMedical devicesVUNO
Previous Post

VideoMonster: A one-stop video-making platform for effortless professional videos

Next Post

Korean startup Jongdal Lab wants to digitize fashion material sourcing with Buja Market

Next Post
Buja Market serves fashion manufacturers for source material.

Korean startup Jongdal Lab wants to digitize fashion material sourcing with Buja Market

0 0 votes
Article Rating
Subscribe
Login
Notify of
Please login to comment
0 Comments
Inline Feedbacks
View all comments
No Result
View All Result

Follow Us

FREE NEWSLETTER

Ecosystem Partners




PRODUCTS

Most Popular

  • 10 K-Dramas to watch for some ‘money matters’

    0 shares
    Share 0 Tweet 0
  • Korean startups fall short on global readiness, finds Open Innovation Trend survey

    0 shares
    Share 0 Tweet 0
  • UNDP-Citi Foundation’s impact startup acceleration programme ‘Citypreneurs 2023’ to promote innovative solutions for urban sustainability

    0 shares
    Share 0 Tweet 0
  • Top Korean Dating apps that can help you make new connections in South Korea

    1 shares
    Share 0 Tweet 0
  • Three Restaurant Apps to try out for a fine dining experience in South Korea  

    9 shares
    Share 9 Tweet 0
  • Fabless semiconductor startup Fadu raises pre-IPO funding, becomes this year’s first Korean unicorn

    0 shares
    Share 0 Tweet 0
  • Quantit secures  30 billion won Series A investment from Smilegate Holdings for AI-based FinTech Asset Management Services

    0 shares
    Share 0 Tweet 0
  • Korean startup launching a nose-print identification for dogs, an alternate to the microchip embedding process

    0 shares
    Share 0 Tweet 0
  • Afun Interactive receives investment for Virtual K-Pop Content Production

    0 shares
    Share 0 Tweet 0
  • Korean government pledges to nurture K-Space startups with 50 billion won ‘space fund’

    0 shares
    Share 0 Tweet 0
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KTO
    • KOTRA
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login

Copyright © 2023 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback

dgdfgfdgdf

What you think about Koreatechdesk, Share your idea with us!

feedback popup

Invitation submission has been closed

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.